论文部分内容阅读
目的探讨子宫动脉灌注化疗栓塞术后期待治疗应用于剖宫产瘢痕妊娠(cesarean scar pregnancy,CSP)的疗效和安全性。方法选取2007年1月至2014年7月重庆三峡中心医院江南分院诊治的80例外向型CSP患者的病历资料,根据治疗方案选择的不同将子宫动脉灌注化疗栓塞术后期待治疗(不清宫)的40例作为研究组,子宫动脉灌注化疗栓塞联合彩超监测下清宫治疗的40例为对照组,对比分析两组治疗的有效性和安全性。结果两组治疗有效性比较差异无统计学意义(P>0.05)。研究组的阴道出血量、平均住院时间明显少于对照组(P<0.05)。结论子宫动脉灌注化疗栓塞术后期待治疗CSP,具有出血量少、住院时间短、治疗效果明显等优点,避免了清宫带来的大出血、子宫穿孔等风险,减轻了患者痛苦和经济负担,值得临床推广。
Objective To investigate the efficacy and safety of uterine arterial infusion chemotherapy and embolization in the treatment of cesarean scar pregnancy (CSP). Methods From January 2007 to July 2014, three cases of CSP patients diagnosed and treated in Jiangnan Branch of Chongqing Three Gorges Central Hospital were enrolled in this study. According to the different treatment options, uterine arterial infusion 40 cases as the research group, uterine arterial infusion chemoembolization combined with color Doppler ultrasonography treatment of 40 cases of the control group, comparative analysis of the two groups of the effectiveness and safety of treatment. Results There was no significant difference in therapeutic effectiveness between the two groups (P> 0.05). The study group vaginal bleeding, the average length of stay was significantly less than the control group (P <0.05). Conclusion Uterine arterial chemoembolization is expected to be treated CEP after surgery, with less bleeding, shorter hospital stay, the treatment effect is obvious, etc., to avoid the risk of bleeding, uterine perforation caused by Qing, reducing the patient’s suffering and financial burden, it is worth clinical Promotion.